Changes of NLRP3 in serum and cerebrospinal fluid of patients after moderate to severe traumatic brain injury and their predictive values for prognosis
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.70009 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Wei Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Brain Injuries, Traumatic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Project of Ningbo Municipal Bureau of Science and Technology, Project of Ningbo Leading Medical & Health Discipline.
Abstract (Originalsprache)
Background
Traumatic brain injury (TBI) remains a major concern for global health. Recent studies have suggested the role of NOD‐like receptor pyrin domain‐containing protein 3 (NLRP3), an inflammatory marker, in the cerebrospinal fluid (CSF) and serum as potential indicators of TBI prognosis. The objective of the study was to characterize NLRP3 as a clinically applicable tool for predicting the outcomes of TBI patients.
Methods
A total of 270 patients with moderate to severe TBI were included in this retrospective analysis. Serum and CSF samples were collected at 1‐, 3‐, 7‐, and 21‐day post‐injury to measure NLRP3 levels. The prognosis of patients was evaluated after 3 months using the Glasgow Outcome Scale (GOS). Patients were categorized into good prognosis (GOS score >3) and poor prognosis (GOS score ≤3) groups. The relationship between NLRP3 levels and prognosis was analyzed.
Results
Patients with poor prognosis had significantly elevated NLRP3 levels in their serum on days 1 and 3 post‐injury compared with those with a good prognosis. The difference was more pronounced during these early days compared with days 7 and 21. However, NLRP3 levels in CSF consistently showed a large difference between the two groups throughout the observation period. Receiver operating characteristic analysis revealed that the level of NLRP3 in the CSF on day 3 post‐injury had the highest predictive value for prognosis, with an area under the curve of 0.83, followed by the level of NLRP3 in the serum on day 3 post‐injury.
Conclusions
The levels of NLRP3, especially in the CSF on day 3 post‐injury, can serve as a potential biomarker for predicting prognosis in moderate to severe TBI patients. Early measurement of NLRP3 levels can provide valuable insights into patient outcomes and guide therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, China.
- Department of Neurosurgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
ORCID-Profile: Wei Chen
Förderung
- National Natural Science Foundation of China
- Project of Ningbo Municipal Bureau of Science and Technology
- Project of Ningbo Leading Medical & Health Discipline
- the Scientific Research Project of Jiangxi Provincial Department of Education
- Key Research & Development Project of Jiangxi Provincial Department of Science and Technology
Zitieren
APA
Chen, W., Wang, Z., Ye, G., Zhu, G., Li, S., Chen, P., Wang, H., Zou, S., & Chen, M. (2024). Changes of NLRP3 in serum and cerebrospinal fluid of patients after moderate to severe traumatic brain injury and their predictive values for prognosis. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70009
Vancouver
Chen W, Wang Z, Ye G, Zhu G, Li S, Chen P, et al. Changes of NLRP3 in serum and cerebrospinal fluid of patients after moderate to severe traumatic brain injury and their predictive values for prognosis. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.70009
BibTeX
@article{Chen2024,
author = {Chen, Wei and Wang, Zhigang and Ye, Gengfan and Zhu, Guangyao and Li, Shiwei and Chen, Pandi and Wang, Hongcai and Zou, Shufeng and Chen, Maosong},
title = {Changes of NLRP3 in serum and cerebrospinal fluid of patients after moderate to severe traumatic brain injury and their predictive values for prognosis},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.70009}
}
EUVIMED